Data Integrity Fallout: Sponsors Risk Reputational Damage, Negative Impacts On Other Research

US is going after fraudulent clinical trial conduct, and sponsors may be faced with determining the breadth of such fraud, whether studies will be delayed and impacts on other development programs; how a sponsor handles potential fraud could define their future interactions with FDA, DoJ.